During the past decade, Wake Forest Health Sciences Dermatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Forest Health Sciences Dermatology" #1 collaborator was "Galderma R&D" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wake Forest Health Sciences Dermatology" are "Rosacea" (2 trials), "Actinic Keratosis" (1 trials), "Atopic Dermatitis" (1 trials), "Hidradenitis Suppurativa" (1 trials) and "Hidradenitis Suppurativa (HS)" (1 trials). Many other conditions were trialed in "Wake Forest Health Sciences Dermatology" in a lesser frequency.

Most popular intervention types in "Wake Forest Health Sciences Dermatology" are "Drug" (4 trials), "Behavioral" (2 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "AKRQ questionnaire" (1 trials), "Adalimumab" (1 trials), "Control Group Oral Survey 1" (1 trials), "Electronic Reporting" (1 trials) and "GPSkin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wake Forest Health Sciences Dermatology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Wake Forest Health Sciences Dermatology". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Wake Forest Health Sciences Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wake Forest Health Sciences Dermatology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".